BACKGROUND & AIMS: The aryl hydrocarbon receptor (AhR) also known as the dioxin receptor or xenobiotic receptor is a member of the basic helix-loop-helix/period AhR nuclear translocator single minded family. The goal of this study was to determine the endobiotic role of AhR in hepatic steatosis. METHODS: Wild-type, constitutively activated AhR transgenic, AhR null and CD36/fatty acid translocase null mice were used to investigate the role of AhR in steatosis and the involvement of CD36 in the steatotic effect of AhR. The promoters of the mouse and human CD36 genes were cloned and their regulation by AhR was analyzed. RESULTS: Activation of AhR induced spontaneous hepatic steatosis characterized by the accumulation of triglycerides. The steatotic effect of AhR likely is owing to the combined up-regulation of CD36 and fatty acid transport proteins, suppression of fatty acid oxidation, inhibition of hepatic export of triglycerides, increase in peripheral fat mobilization, and increased hepatic oxidative stress. Promoter analysis established CD36 as a novel transcriptional target of AhR. Activation of AhR in liver cells induced CD36 gene expression and enhanced fatty acid uptake. The steatotic effect of an AhR agonist was inhibited in CD36-/- mice. CONCLUSIONS: Our study reveals a novel link between AhR-induced steatosis and the expression of CD36. Industrial or military exposures to dioxin and related compounds have been linked to increased prevalence of fatty liver in human beings. Results from this study may help to establish AhR and its target CD36 as novel therapeutic and preventive targets for fatty liver disease. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
BACKGROUND & AIMS: The aryl hydrocarbon receptor (AhR) also known as the dioxin receptor or xenobiotic receptor is a member of the basic helix-loop-helix/period AhR nuclear translocator single minded family. The goal of this study was to determine the endobiotic role of AhR in hepatic steatosis. METHODS: Wild-type, constitutively activated AhR transgenic, AhR null and CD36/fatty acid translocase null mice were used to investigate the role of AhR in steatosis and the involvement of CD36 in the steatotic effect of AhR. The promoters of the mouse and human CD36 genes were cloned and their regulation by AhR was analyzed. RESULTS: Activation of AhR induced spontaneous hepatic steatosis characterized by the accumulation of triglycerides. The steatotic effect of AhR likely is owing to the combined up-regulation of CD36 and fatty acid transport proteins, suppression of fatty acid oxidation, inhibition of hepatic export of triglycerides, increase in peripheral fat mobilization, and increased hepatic oxidative stress. Promoter analysis established CD36 as a novel transcriptional target of AhR. Activation of AhR in liver cells induced CD36 gene expression and enhanced fatty acid uptake. The steatotic effect of an AhR agonist was inhibited in CD36-/- mice. CONCLUSIONS: Our study reveals a novel link between AhR-induced steatosis and the expression of CD36. Industrial or military exposures to dioxin and related compounds have been linked to increased prevalence of fatty liver in human beings. Results from this study may help to establish AhR and its target CD36 as novel therapeutic and preventive targets for fatty liver disease. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Authors: Dario Greco; Anna Kotronen; Jukka Westerbacka; Oscar Puig; Perttu Arkkila; Tuula Kiviluoto; Saara Laitinen; Maria Kolak; Rachel M Fisher; Anders Hamsten; Petri Auvinen; Hannele Yki-Järvinen Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-04-03 Impact factor: 4.052
Authors: M Febbraio; N A Abumrad; D P Hajjar; K Sharma; W Cheng; S F Pearce; R L Silverstein Journal: J Biol Chem Date: 1999-07-02 Impact factor: 5.157
Authors: P Fernandez-Salguero; T Pineau; D M Hilbert; T McPhail; S S Lee; S Kimura; D W Nebert; S Rudikoff; J M Ward; F J Gonzalez Journal: Science Date: 1995-05-05 Impact factor: 47.728
Authors: Shaimaa Ahmed; Debbie Bott; Alvin Gomez; Laura Tamblyn; Adil Rasheed; Tiffany Cho; Laura MacPherson; Kim S Sugamori; Yang Yang; Denis M Grant; Carolyn L Cummins; Jason Matthews Journal: J Biol Chem Date: 2015-05-13 Impact factor: 5.157
Authors: Ian K Lai; Kiran Dhakal; Gopi S Gadupudi; Miao Li; Gabriele Ludewig; Larry W Robertson; Alicia K Olivier Journal: Toxicology Date: 2012-07-21 Impact factor: 4.221
Authors: Isabelle R Miousse; Charles M Skinner; Haixia Lin; Laura E Ewing; Stanley D Kosanke; D Keith Williams; Bharathi Avula; Ikhlas A Khan; Mahmoud A ElSohly; Bill J Gurley; Igor Koturbash Journal: Food Chem Toxicol Date: 2017-08-24 Impact factor: 6.023
Authors: Wojciech G Garbacz; Peipei Lu; Tricia M Miller; Samuel M Poloyac; Nicholas S Eyre; Graham Mayrhofer; Meishu Xu; Songrong Ren; Wen Xie Journal: Mol Cell Biol Date: 2016-10-13 Impact factor: 4.272
Authors: Rance Nault; Kelly A Fader; Dustin A Ammendolia; Peter Dornbos; Dave Potter; Bonnie Sharratt; Kazuyoshi Kumagai; Jack R Harkema; Sophia Y Lunt; Jason Matthews; Tim Zacharewski Journal: Toxicol Sci Date: 2016-08-25 Impact factor: 4.849